The lantibiotic lacticin 3147 prevents systemic spread of staphylococcus aureus in a murine infection model

International Journal of Microbiology

Volumn , Issue , 2012, Pages

  Piper, Clare ^a   Casey, Pat G ^a,b   Hill, Colin ^a,b   Cotter, Paul D ^b,c   Ross, R Paul ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE; MUS; STAPHYLOCOCCUS AUREUS;

EID: 84856479279     PISSN: 1687918X     EISSN: 16879198     Source Type: Journal    
DOI: 10.1155/2012/806230     Document Type: Article

References (43)

1. Rennie R. P., Jones R. N., Mutnick A. H., Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000) Diagnostic Microbiology and Infectious Disease 2003 45 4 287 293 (Pubitemid 36555681)
2. Tucu A., Yildirimtrk., Baytarolu C., Kurtolu H., Kse., ener M., Aytekin S., Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey Turk Kardiyoloji Dernegi Arsivi 2009 37 1 9 18
3. Nomura A., Omata F., Furukawa K., Risk factors of mid-term mortality of patients with infective endocarditis European Journal of Clinical Microbiology and Infectious Diseases 2010 29 11 1355 1360
4. Valente A. M., Jain R., Scheurer M., Fowler V. G., Corey G. R., Bengur A. R., Sanders S., Li J. S., Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia Pediatrics 2005 115 1 e15 e19
5. Boyce J. M., Cookson B., Christiansen K., Hori S., Vuopio-Varkila J., Kocagz S., ztop A. Y., Vandenbroucke-Grauls C. M. J. E., Harbarth S., Pittet D., Meticillin-resistant Staphylococcus aureus Lancet Infectious Diseases 2005 5 10 653 663 (Pubitemid 41383911)
6. Cosgrove S. E., Sakoulas G., Perencevich E. N., Schwaber M. J., Karchmer A. W., Carmeli Y., Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clinical Infectious Diseases 2003 36 1 53 59 (Pubitemid 36099097)
7. Pittet D., Tarara D., Wenzel R. P., Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality Journal of the American Medical Association 1994 271 20 1598 1601
8. Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P., Nosocomial infections in combined medical-surgical intensive care units in the United States Infection Control and Hospital Epidemiology 2000 21 8 510 515 (Pubitemid 30647154)
9. Cui L., Iwamoto A., Lian J. Q., Neoh H. M., Maruyama T., Horikawa Y., Hiramatsu K., Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus Antimicrobial Agents and Chemotherapy 2006 50 2 428 438 (Pubitemid 43190949)
10. Hiramatsu K., Vancomycin resistance in staphylococci Drug Resistance Updates 1998 1 2 135 150
11. Schnell N., Entian K. D., Schneider U., Gotz F., Zahner H., Kellner R., Jung G., Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings Nature 1988 333 6170 276 278
12. Fontana M. B. C., Freire De Bastos M. D. C., Brandelli A., Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters Current Microbiology 2006 52 5 350 353
13. Brumfitt W., Salton M. R. J., Hamilton-Miller J. M. T., Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci Journal of Antimicrobial Chemotherapy 2002 50 5 731 734 (Pubitemid 35331693)
14. Piper C., Draper L. A., Cotter P. D., Ross R. P., Hill C., A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species Journal of Antimicrobial Chemotherapy 2009 64 3 546 551
15. Piper C., Hill C., Cotter P. D., Ross R. P., Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z Microbial Biotechnology 2011 4 3 375 382
16. Mota-Meira M., Morency H., Lavoie M. C., In vivo activity of mutacin B-Ny266 Journal of Antimicrobial Chemotherapy 2005 56 5 869 871 (Pubitemid 41631910)
17. Castiglione F., Lazzarini A., Carrano L., Corti E., Ciciliato I., Gastaldo L., Candiani P., Losi D., Marinelli F., Selva E., Parenti F., Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens Chemistry and Biology 2008 15 1 22 31
18. De Kwaadsteniet M., Doeschate K. T., Dicks L. M. T., Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus Letters in Applied Microbiology 2009 48 1 65 70
19. Brand A. M., de Kwaadsteniet M., Dicks L. M. T., The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice Letters in Applied Microbiology 2010 51 6 645 649
20. Kruszewska D., Sahl H. G., Bierbaum G., Pag U., Hynes S. O., Ljungh A., Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model Journal of Antimicrobial Chemotherapy 2004 54 3 648 653 (Pubitemid 39263907)
21. Chatterjee S., Chatterjee D. K., Jani R. H., Blumbach J., Ganguli B. N., Klesel N., Limbert M., Seibert G., Mersacidin, a new antibiotic from bacillus in vitro and in vivo antibacterial activity Journal of Antibiotics 1992 45 6 839 845
22. Lawton E. M., Ross R. P., Hill C., Cotter P. D., Two-peptide lantibiotics: a medical perspective Mini-Reviews in Medicinal Chemistry 2007 7 12 1236 1247 (Pubitemid 350303085)
23. Suda S., Cotter P. D., Hill C., Ross R. P., Lacticin 3147biosynthesis, molecular analysis, immunity, bioengineering and applications. Current Protein and Peptide Science. In press
24. Rea M. C., Clayton E., O'Connor P. M., Shanahan F., Kiely B., Ross R. P., Hill C., Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains Journal of Medical Microbiology 2007 56 7 940 946 (Pubitemid 47047488)
25. Galvin M., Hill C., Ross R. P., Lacticin 3147 displays activity in buffer against Gram-positive bacterial pathogens which appear insensitive in standard plate assays Letters in Applied Microbiology 1999 28 5 355 358 (Pubitemid 29229506)
26. Rea M. C., Dobson A., O'Sullivan O., Crispie F., Fouhy F., Cotter P. D., Shanahan F., Kiely B., Hill C., Paul Ross R., Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon Proceedings of the National Academy of Sciences of the United States of America 2011 108 supplement 1 4639 4644
27. Carroll J., Draper L. A., O'Connor P. M., Coffey A., Hill C., Ross R. P., Cotter P. D., O'Mahony J., Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria International Journal of Antimicrobial Agents 2010 36 2 132 136
28. Twomey D. P., Wheelock A. I., Flynn J., Meaney W. J., Hill C., Ross R. P., Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, Lacticin 3147 Journal of Dairy Science 2000 83 9 1981 1988
29. Ryan M. P., Meaney W. J., Ross R. P., Hill C., Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens Applied and Environmental Microbiology 1998 64 6 2287 2290 (Pubitemid 28252803)
30. Klostermann K., Crispie F., Flynn J., Meaney W. J., Paul Ross R., Hill C., Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis Journal of Dairy Research 2010 77 2 231 238
31. Mortin L. I., Li T., Van Praagh A. D. G., Zhang S., Zhang X. X., Alder J. D., Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria Antimicrobial Agents and Chemotherapy 2007 51 5 1787 1794 (Pubitemid 46744159)
32. Contag C. H., Contag P. R., Mullins J. I., Spilman S. D., Benaron D. A., Photonic detection of bacterial pathogens in living hosts Molecular Microbiology 1995 18 4 593 603 (Pubitemid 26008843)
33. Contag C. H., Spilman S. D., Contag P. R., Oshiro M., Eames B., Dennery P., Stevenson D. K., Benaron D. A., Visualizing gene expression in living mammals using a bioluminescent reporter Photochemistry and Photobiology 1997 66 4 523 531 (Pubitemid 127470201)
34. Francis K. P., Joh D., Bellinger-Kawahara C., Hawkinson M. J., Purchio T. F., Contag P. R., Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct Infection and Immunity 2000 68 6 3594 3600 (Pubitemid 30340463)
35. Hickey M. J., Arain T. M., Shawar R. M., Humble D. J., Langhorne M. H., Morgenroth J. N., Stover C. K., Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice Antimicrobial Agents and Chemotherapy 1996 40 2 400 407 (Pubitemid 26053139)
36. Rocchetta H. L., Boylan C. J., Foley J. W., Iversen P. W., Letourneau D. L., McMillian C. L., Contag P. R., Jenkins D. E., Parr T. R., Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection Antimicrobial Agents and Chemotherapy 2001 45 1 129 137 (Pubitemid 32039104)
37. Breukink E., A lesson in efficient killing from two-component lantibiotics Molecular Microbiology 2006 61 2 271 273 (Pubitemid 44356560)
38. Wiedemann I., Bttiger T., Bonelli R. R., Wiese A., Hagge S. O., Gutsmann T., Seydel U., Deegan L., Hill C., Ross P., Sahl H. G., The mode of action of the lantibiotic lacticin 3147a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II Molecular Microbiology 2006 61 2 285 296 (Pubitemid 44356563)
39. Brtz H., Bierbaum G., Leopold K., Reynolds P. E., Sahl H. G., The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II Antimicrobial Agents and Chemotherapy 1998 42 1 154 160 (Pubitemid 28053343)
40. Chatterjee S., Chatterjee S., Lad S. J., Phansalkar M. S., Rupp R. H., Ganguli B. N., Fehlhaber H. W., Kogler H., Mersacidin, a new antibiotic from bacillus fermentation, isolation, purification and chemical characterization Journal of Antibiotics 1992 45 6 832 838
41. Ryan M. P., McAuliffe O., Ross R. P., Hill C., Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin Letters in Applied Microbiology 2001 32 2 71 77 (Pubitemid 32158723)
42. Morgan S. M., O'Connor P. M., Cotter P. D., Ross R. P., Hill C., Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations Antimicrobial Agents and Chemotherapy 2005 49 7 2606 2611 (Pubitemid 40917568)
43. Suda S., Westerbeek A., O'Connor P. M., Ross R. P., Hill C., Cotter P. D., Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases Chemistry and Biology 2010 17 10 1151 1160